Why It Matters
This successful and large-scale IPO provides Apotex with substantial capital for future growth and strategic initiatives, while also demonstrating robust investor confidence in the pharmaceutical sector and the Canadian public market.
Key Intelligence
- ■Apotex Inc. and its backers successfully raised C$932 million (US$681 million) in its initial public offering on the Toronto Stock Exchange.
- ■The IPO was priced at C$24 per share, reaching the top end of its marketed range, indicating strong investor demand.
- ■This marks one of the largest initial public offerings in Canada this year.